Yinggang Capital has launched new funds to invest in emerging technologies, including digital economy, robotics, and AI, while emphasizing the integration of technology to enhance social welfare in Jiangsu province.

Target Information

Yinggang Capital has established new funds aiming to invest heavily in emerging technologies, specifically setting up digital industry, robotics, and AI funds in Jiangsu for the year 2025. These funds focus on the digital economy, the robotics industry chain, and AI applications, while aligning with the local government's industrial strategies and the operational needs of technology enterprises. Yinggang Capital is committed to building a collaborative development platform integrating 'funds + ecosystems + regions' to drive regional growth.

Since its inception, Yinggang Capital has managed over 8 billion RMB and USD, directing investments into sectors such as robotics, AI, smart driving, low-altitude economy, semiconductors, the internet, and healthcare technology. Their notable portfolio includes leading firms such as Pudong Robotics, Jiangsu TianTong Vision (an intelligent driving enterprise), and Huazhong University of Science and Technology. Through strategic investments, Yinggang Capital aims to enhance industry capacities across various cutting-edge technological fields, showcasing a significant focus on high-precision robotics and AI-driven applications.

Industry Overview

The emerging technology industry in China, particularly in Jiangsu, is experiencing transformative growth driven by state policies and market demands. The province is recognized for its robust manufacturing base and rapid advance

View Source

Similar Deals

L Catterton 人民币基金

2025

Other Closed End Funds China
JD Capital Zhongjie Insurance Brokerage Co., Ltd.

2023

Other Multiline Insurance & Brokers (NEC) China
Toyo Securities Double Check

2026

Other Investment Banking & Brokerage Services (NEC) Japan
Generali Česká pojišťovna D.A.S. právní ochrana

2026

Other Casualty Insurance Czech Republic
Ares Management BlueCove

2026

Other Mutual Funds (NEC) United Kingdom
Adicon Holdings Limited Crown Bioscience Inc.

2026

Other Biotechnology & Medical Research (NEC) China

盈港资本

invested in

天瞳威视

in 2025

in a Other deal

Disclosed details

Transaction Size: $725M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert